Literature DB >> 14697314

Survival of neuronal tissue following xenograft implantation into the adult rat inner ear.

Zhengqing Hu1, Mats Ulfendahl, N Petri Olivius.   

Abstract

The poor regenerative capacity of the spiral ganglion neurons of the mammalian inner ear has initiated research on how to assist the functional recovery of the injured auditory system. A possible treatment is to use a biological implant with a potential to establish central or peripheral synaptic contacts to develop into a functional auditory unit. The feasibility of this approach was tested by xenograft implantation of dorsal root ganglion (DRG) neurons from embryonic days 13 to 14, mouse expressing either LacZ or enhanced green fluorescent protein (EGFP) into the scala tympani of the adult rat inner ear. Transplanted DRG neurons survived in the scala tympani for a postoperative period ranging from 3 to 10 weeks, as verified by histochemical detection of LacZ, EGFP fluorescence and immunohistochemical labeling of the neuronal markers neurofilament and Thy 1.2. DRG neurons were found close to structures near the sensory epithelium (the organ of Corti) as well as adjacent to the spiral ganglion neurons with their peripheral dendrites. These results illustrate not only the survival of xenografted DRG neurons in the adult inner ear but also the feasibility of a neuronal transplantation strategy in the degenerated auditory system, thereby creating possibilities to replace spiral ganglion neurons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14697314     DOI: 10.1016/j.expneurol.2003.09.013

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  14 in total

Review 1.  The convergence of cochlear implantation with induced pluripotent stem cell therapy.

Authors:  Niliksha Gunewardene; Mirella Dottori; Bryony A Nayagam
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

2.  Fate of embryonic stem cells transplanted into the deafened mammalian cochlea.

Authors:  B Coleman; J Hardman; A Coco; S Epp; M de Silva; J Crook; R Shepherd
Journal:  Cell Transplant       Date:  2006       Impact factor: 4.064

Review 3.  The potential of stem cells for the restoration of auditory function in humans.

Authors:  Zhengqing Hu; Mats Ulfendahl
Journal:  Regen Med       Date:  2013-05       Impact factor: 3.806

4.  Concomitant differentiation of a population of mouse embryonic stem cells into neuron-like cells and schwann cell-like cells in a slow-flow microfluidic device.

Authors:  Poornapriya Ramamurthy; Joshua B White; Joong Yull Park; Richard I Hume; Fumi Ebisu; Flor Mendez; Shuichi Takayama; Kate F Barald
Journal:  Dev Dyn       Date:  2016-11-17       Impact factor: 3.780

Review 5.  Clinical application of neurotrophic factors: the potential for primary auditory neuron protection.

Authors:  Lisa N Gillespie; Robert K Shepherd
Journal:  Eur J Neurosci       Date:  2005-11       Impact factor: 3.386

6.  Netrin-1-mediated axon guidance in mouse embryonic stem cells overexpressing neurogenin-1.

Authors:  Gerhard W Hill; Erin K Purcell; Liqian Liu; John Matthew Velkey; Richard A Altschuler; Robert Keith Duncan
Journal:  Stem Cells Dev       Date:  2012-06-04       Impact factor: 3.272

Review 7.  Challenges for stem cells to functionally repair the damaged auditory nerve.

Authors:  Karina Needham; Ricki L Minter; Robert K Shepherd; Bryony A Nayagam
Journal:  Expert Opin Biol Ther       Date:  2012-10-25       Impact factor: 4.388

8.  Functional evaluation of a cell replacement therapy in the inner ear.

Authors:  Zhengqing Hu; Mats Ulfendahl; Diane M Prieskorn; Petri Olivius; Josef M Miller
Journal:  Otol Neurotol       Date:  2009-06       Impact factor: 2.311

9.  Surgical access to the mammalian cochlea for cell-based therapies.

Authors:  Steven Backhouse; Bryony Coleman; Robert Shepherd
Journal:  Exp Neurol       Date:  2008-08-16       Impact factor: 5.330

10.  Deferoxamine promotes mesenchymal stem cell homing in noise-induced injured cochlea through PI3K/AKT pathway.

Authors:  A A Peyvandi; H-A Abbaszadeh; N Ahmady Roozbahany; A Pourbakht; S Khoshsirat; H Haddadzade Niri; H Peyvandi; S Niknazar
Journal:  Cell Prolif       Date:  2018-01-17       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.